Certara Outlines Strategic Realignment and AI Initiatives at Jefferies Conference
Certara (NASDAQ:CERT) outlined its strategic realignment, artificial intelligence initiatives, cost-cutting measures, and new growth engines during a presentation at the Jefferies Global Healthcare Conference. The company is focusing on two key areas: ACE for accelerating clinical evidence and MID3 for model-informed drug development.
Topics: AI clinical trials cost-cutting growth strategy